Clinical Scorecard: Cortical Spreading Depolarization Induces Inflammatory Signaling Pathways: Implications for Headache Development
At a Glance
Category
Detail
Condition
Migraine headaches associated with cortical spreading depolarization (CSD)
Key Mechanisms
CSD triggers neuronal release of pro-inflammatory mediators activating NF-κB in astrocytes and microglia, leading to meningeal inflammation and headache
Target Population
Patients experiencing migraine with aura
Care Setting
Neurology and headache specialty clinics, research settings
Key Highlights
CSD initiates pro-inflammatory signaling via neuronal release of HMGB1 and activation of caspase-1, peaking within hours post-CSD.
Astrocytes exhibit a shift from pro-inflammatory NF-κB p65:p50 activity to anti-inflammatory cRel:p65 activity within 24 hours post-CSD.
Microglia contribute to inflammatory responses and synaptic repair through chemokine and cytokine release, supporting resolution of inflammation.
Guideline-Based Recommendations
Diagnosis
Consider CSD-related inflammatory signaling as a mechanism underlying migraine with aura.
Utilize imaging modalities such as PET with [11C]PBR28 to detect glial inflammation in parenchymal and meningeal regions.
Management
Target NF-κB pathways to suppress CSD-induced meningeal artery dilation and trigeminovascular activation.
Modulate astrocyte function to reduce dural nociceptor sensitization and inflammatory mediator release.
Monitoring & Follow-up
Assess inflammatory mediator levels and glial activation markers post-CSD to evaluate progression and resolution of inflammation.
Risks
Incomplete resolution of inflammation may contribute to chronic migraine development.
Persistent pro-inflammatory signaling could exacerbate headache severity and duration.
Patient & Prescribing Data
Individuals with migraine with aura experiencing CSD-related headaches
Therapies targeting inflammatory signaling pathways, particularly NF-κB inhibition and astrocyte modulation, may alleviate headache symptoms and prevent progression.
Clinical Best Practices
Recognize the role of neuroinflammation in migraine pathophysiology to guide targeted therapeutic strategies.
Employ multidisciplinary approaches combining neuroimaging, molecular assays, and clinical evaluation for comprehensive management.
Monitor inflammatory and anti-inflammatory mediator dynamics to optimize timing and selection of interventions.
